14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for RCKT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 23.99 6.04 %
R2 23.56 4.17 %
R1 23.30 3.01 %
Current price: 22.62
Support S1 22.45 -0.740 %
S2 22.19 -1.90 %
S3 21.77 -3.77 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 26.81 18.52 %
R2 23.63 4.47 %
R1 22.80 0.796 %
Current price 22.62
Support S1 22.53 -0.398%
S2 22.10 -2.30%
S3 21.98 -2.83%

RCKT Predictions History

10 months ago
RKP predicted that RCKT for 2023-07-18 is going $19.25 (1.10%)

10 months ago
RKP predicted that RCKT for 2023-07-14 is going $20.30 (2.94%)

10 months ago
RKP predicted that RCKT for 2023-07-12 is going $19.20 (-3.71%)

10 months ago
RKP predicted that RCKT for 2023-06-21 is going $23.00 (5.55%)

10 months ago
RKP predicted that RCKT for 2023-06-20 is going $22.50 (-0.40%)

11 months ago
RKP predicted that RCKT for 2023-06-16 is going $23.05 (5.25%)

11 months ago
RKP predicted that RCKT for 2023-06-14 is going $24.12 (6.30%)

11 months ago
RKP predicted that RCKT for 2023-06-07 is going $23.60 (1.68%)

11 months ago
PredictionBot.Kathy predicted that RCKT for 2023-06-07 is going $22.74 (-2.03%)

11 months ago
PredictionBot.Warren predicted that RCKT for 2023-06-07 is going $22.90 (-1.33%)

Click to get the best stock tips daily for free!

About Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder ... RCKT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT